Risk factors of anxiety and depression in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 11, 2012, Pages 2086-2091

  Nahon, Stéphane ^a   Lahmek, Pierre ^b   Durance, Christelle ^a,c   Olympie, Alain ^c   Lesgourgues, Bruno ^a   Colombel, Jean Frédéric ^c,d   Gendre, Jean Pierre ^c  

^a Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

^b Hôpitaux Universitaires Henri Mondor   (France)

^c Association François Aupetit   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

anxiety; depression; IBD; risk factors

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; CORTICOSTEROID; MESALAZINE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; DEPRESSION; DISABILITY; DISEASE EXACERBATION; DISEASE SEVERITY; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; UNEMPLOYMENT;

ADULT; ANXIETY DISORDERS; CROHN DISEASE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84867575554     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22888     Document Type: Article

References (24)

1. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007; 13: 225-234.
2. Graff LA, Walker JR, Bernstein CN,. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009; 15: 1105-1118.
3. Häuser W, Janke KH, Klump B, et al. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2011; 17: 621-632.
4. Graff LA, Walker JR, Clara I, et al. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009; 104: 2959-2969.
5. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008; 103: 1989-1997.
6. Trachter AB, Rogers AI, Leiblum SR,. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm Bowel Dis. 2002; 8: 413-421.
7. Fuller-Thomson E, Sulman J,. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006; 12: 697-707.
8. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008; 14: 1273-1280.
9. Lorant V, Deliège D, Eaton W, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003; 157: 98-112.
10. Nahon S, Lahmek P, Saas C, et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm Bowel Dis. 2011; 17: 1270-1276.
11. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006; 130: 650-656.
12. Kane SV,. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006; 23: 577-585.
13. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-70.
14. Nahon S, Lahmek P, Macaigne G, et al. Socioeconomic deprivation does not influence the severity of Crohn's disease: results of a prospective multicenter study. Inflamm Bowel Dis. 2009; 15: 594-598.
15. Sass C, Dupré C, Dauphinot V, et al. The EPICES score: an individual index of material and social deprivation related to health status. Part 2. Evaluation in a population of 197 389 subjects [article online] 2005. Available from: http://www.cetaf.asso.fr/protocoles/precarite/protocoles-epices. htm#publis
16. Sass C, Guéguen R, Moulin JJ, et al. Comparison of the individual deprivation index of the French Health Examination Centres and the administrative definition of deprivation. Sante Publique. 2006; 18: 513-522.
17. Guéguen R, Sass C, the EPICES Working Group. The EPICES score: an individual index of material and social deprivation related to health status. Part 1. Setting up the score [article online] 2005. Available from: http://www.cetaf.asso.fr/protocoles/precarite/protocoles-epices. htm#publis
18. Leray E, Camara A, Drapier D, et al. Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" Survey (MHGP). Eur Psychiatry. 2011; 26: 339-345.
19. Norton J, de Roquefeuil G, David M, et al. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription.] Encephale. 2009; 35: 560-569.
20. Yazdanpanah Y, Klein O, Gambiez L, et al. Impact of surgery on quality of life in Crohn's disease. Am J Gastroenterol. 1997; 92: 1897-1900.
21. Yang YX, Lichtenstein GR,. Corticosteroids in Crohn's disease. Am J Gastroenterol. 2002; 97: 803-823.
22. Warrington TP, Bostwick JM,. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006; 81: 1361-1367.
23. Lewis DA, Smith RE,. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord. 1983; 5: 319-332.
24. Calvet X, Gallardo O, Coronas R, et al. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease. Inflamm Bowel Dis. 2006; 12: 692-696.